Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure
Keyword(s):
ABSTRACT We reviewed 37 patients treated for bacteremia due to carbapenem-resistant (CR) Pseudomonas aeruginosa. Although 65% of isolates were multiple-drug resistant, therapeutic options were available, as all were susceptible to ≥1 antibiotic. A total of 92% of patients received active antimicrobial therapy, but only 57% received early active therapy (within 48 h). Fourteen-day mortality was 19%. Microbiologic failure occurred in 29%. The Pitt bacteremia score (P = 0.046) and delayed active therapy (P = 0.027) were predictive of death and microbiologic failure, respectively.
2017 ◽
Vol 18
(3)
◽
pp. 569
◽
2011 ◽
Vol 77
(19)
◽
pp. 6755-6762
◽
2006 ◽
Vol 34
(12)
◽
pp. 2959-2966
◽
2005 ◽
Vol 11
(2)
◽
pp. 64-70
◽
2002 ◽
Vol 1
(3)
◽
pp. 237-242
◽
Keyword(s):
Keyword(s):
2021 ◽